NCT06751589View on ClinicalTrials.gov

A Study of a Weight Loss Intervention in People With Endometrial Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Endometrial Cancer
Interventions
DRUG

Tirzepatide

2.5 mg administered using a pre-filled injector once weekly for 4 weeks and then increase to 5 mg once weekly.

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester, Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau, Uniondale

11725

RECRUITING

Memorial Sloan Kettering Commack, Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth, Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen, Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER